← Back to Search

Motivational Interviewing for Chronic Kidney Failure Adherence

N/A

Recruiting

Led By Ebele M Umeukeje, MD, MPH

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age and older

Receiving hemodialysis treatments

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 8, week 24

Awards & highlights

Study Summary

This trial tests if a tailored approach to counseling can help kidney patients be more adherent to their treatments. Patients participate in surveys and counseling sessions.

Who is the study for?

The MoVE Trial is for African American adults who are on hemodialysis for kidney failure and have missed or shortened at least one dialysis session. It's not for those planning a transplant, switching to peritoneal dialysis soon, with severe illness or mental impairment, non-English speakers, without documented non-adherence issues, hospitalized or excused absences from treatment.Check my eligibility

What is being tested?

This trial tests if motivational interviewing by health coaches can help patients stick to their hemodialysis schedule. Participants will be randomly placed into two groups: one receiving the intervention and the other not. They'll complete surveys and attend sessions over 24 weeks.See study design

What are the potential side effects?

Since this trial involves motivational interviewing rather than medication, traditional side effects like you'd see with drugs aren't expected. However, participants may experience emotional discomfort discussing personal adherence challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am currently undergoing hemodialysis.

Select...

I have missed or shortened a dialysis session in the last 2 months.

Select...

I have been on hemodialysis for over a month.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 8, week 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 8, week 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8, week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dialysis treatment adherence

Secondary outcome measures

Change in Apathy

Change in Autonomous Regulation

Change in Autonomy Support

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Participants receiving interventionExperimental Treatment1 Intervention

Motivational interviewing intervention

Group II: Standard of CareActive Control1 Intervention

Standard of Care

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Motivational interviewing

2011

Completed Phase 3

~7250

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

857 Previous Clinical Trials

672,043 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,442 Total Patients Enrolled

Ebele M Umeukeje, MD, MPHPrincipal InvestigatorVanderbilt University Medical Center

1 Previous Clinical Trials

30 Total Patients Enrolled

Media Library

Motivational interviewing Clinical Trial Eligibility Overview. Trial Name: NCT05735743 — N/A

Kidney Disease Research Study Groups: Standard of Care, Participants receiving intervention

Kidney Disease Clinical Trial 2023: Motivational interviewing Highlights & Side Effects. Trial Name: NCT05735743 — N/A

Motivational interviewing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05735743 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this research project still ongoing?

"This particular medical study, which was initially listed on November 30th 2023 and last edited February 9th 2023, is no longer recruiting participants. Nonetheless, numerous other clinical trials are currently open to enroll patients as of now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Ebele Umeukeje 2023. "MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05735743.

All > Dialysis